Projeto
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
| Referência: | PTDC/QUI-QIN/0146/2020 |
|---|---|
| Programa de financiamento: | Concurso para Financiamento de Projetos de Investigação Científica e Desenvolvimento Tecnológico em Todos os Domínios Científicos - 2020 |
| Organização financiadora: | Fundação para a Ciência e a Tecnologia |
| Instituições associadas: | Universidade de Lisboa |
Registos relacionados
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
Targeting metastatic breast cancer with innovative ruthenium-peptide conjugates
Targeting cancer with ruthenium compounds
Targeting cancer with ruthenium compounds
Smart ruthenium-peptide prodrugs: a ray of hope in the battle against metastatic breast cancer
Fighting metastatic cancers: prime time for ruthenium
Dendrimers and Dendrons Ruthenium-based Nanosystems to tackle Challenging Cancers
BMX-targeted ligand-drug conjugates for prostate cancer therapy
TRPV1-targeted ligand-drug conjugates to treat prostate cancer
Modulation and targeting of calcium channels with ligand-drug conjugates for cancer therapy
Fighting metastatic cancers: prime time for ruthenium [PTDC/QUI-QIN/28662/2017]
Design of iminoboronate based antitumor targeting conjugates
Site-selective protein-modification chemistries for antibody-drug conjugates (ADCs)
Small molecule cytokine conjugates for cancer treatment
Development of Peptides for Cancer Diagnostics
GENETIC SUSCEPTIBILITY TO BREAST CANCER
Cracking glycan-lectin interactions to target immunosuppressive macrophages in triple-negative breast cancer
Trans-BBB peptides for targeting brain metastasis
Non-invasive, innovative and promising strategy for early diagnosis of breast cancer through the establishment of urinary volatile metabolomic profiles of breast cancer patients as well as from breast cancer tissues and breast cancer cell lines
Design of novel breast tumor ‘targeted` multifunctional nanoparticles
RANK-pathway as a mediator of resistance to cyclin inhibitors and HER2-targeted therapies in breast cancer
PolyTarget - Polyelectrolyte-Based Nanocarriers with Prospects of Targeting Breast Cancer Multiresistances [2022.00764.CEECIND/CP1718/CT0020]
Cell-cell communication in metastatic breast cancer: a control point that can lead to breast cancer treatment
Rab proteins as novel biomarkers in breast cancer
New advance in biomedicine: peptide-mediated target drug delivery
A Small Molecule Drug Conjugate SMDC for Prostate Cancer Therapy
Doctoral Program in Bioengineering - Cell Therapies and Regenerative Medicine - Translating Breast Cancer Immune Features Into Targeted Therapies
Aromatase inhibitors for breast cancer treatment: new molecules and targets to overcome acquired resistance and prevent bone loss
Aromatase inhibitors for breast cancer treatment: new molecules and targets to overcome acquired resistance and prevent bone loss
Targeting a ‘toolbox’ of human microbiome O-Glycan-Selective proteins towards new approaches in cancer research
Exosomes as drug delivery systems in metastatic breast cancer
Role of E-selectin ligands in breast cancer metastasis
New imidazole and chromene-based scaffolds for a multi-target approach on breast cancer therapy [2020.07919.BD]
The blood-brain barrier in brain metastasization of breast cancer: a source of biomarkers, a target for modulation and an obstacle to overcome
Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication.
Doctoral Program MIT Portugal Bio-Engineering Systems Exosomes from Human Mesenchymal Stem/stromal cells for the Delivery of Anticancer Peptides to treat breast cancer
Bolsa de Doutoramento FCT: Breast cancer synergistic therapy based on targeted lipid nanoparticles [SFRH/BD/130147/2017]
A training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates
TARGETING TUMORS WITH INNOVATIVE METAL PEPTIDE COMPLEXAS: IMPROVING EFFICACY IN ANTICANCER DRUGS
MODULATION OF BASE EXCISION REPAIR PATHWAY FOR BREAST CANCER THERAPY
Publicações relacionadas
Carregando publicações...